Publications:100
Accepting New Patients
- Mount Sinai Doctors
- Treats Adults
- Accepting New Patients
Joshua Zeichner, MD
Dermatology
Mount Sinai Doctors - East 85th Street212-241-9728
View location detailsAbout Me
As the Director of Cosmetic and Clinical Research at the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai, Dr. Zeichner has a broad interest in medical and cosmetic dermatology as well as clinical research. His specialty is the treatment of acne, as well as the cosmetic rejuvenation of the aging face. Dr. Zeichner treats general skin conditions, including eczema, rosecea, psoriasis, and skin cancer. In addition, he is well-versed in the use of Botox and dermal fillers, as well as lasers and chemical peels.
Dr. Joshua Zeichner discusses skin cancer in The Daily News feature The Daily Check Up.
Language
English
Position
ASSOCIATE PROFESSOR | Dermatology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Acne
- Acne Scars
- Actinic Keratosis
- Age Spots
- Allergic Contact Dermatitis
- Biopsy
- Birthmarks
- Botox Treatment
- Botulinum Injections-Cosmetic
- Botulinum Toxin for Wrinkles
- Broken Blood Vessels
- Contact Dermatitis
- Eczema
- Epidermal Cyst
- Filler Treatment
- Flushing
- Fractionated Laser Resurfacing
- Hair Loss
- Hemangioma
- Hirsutism
- Hyperhidrosis
- Hyperpigmentation
- Laser Hair Removal
- Laser Resurfacing
- Melasma
- Moles
- Molluscum Contagiosum
- Nevi (Moles)
- Noninvasive Rejuvenation
- Photofacial
- Pigmentary Disorders
- Pigmentation Laser
- Poison Ivy, Poison Oak, Poison Sumac
- Psoriasis
- Rash
- Ringworm
- Rosacea
- Seborrheic Keratosis
- Skin Biopsy
- Skin Cancer
- Skin Care
- Skin Lesion Removal
- Tinea Versicolor
- Vascular Laser
- Warts
- Wrinkles
Education
MD, Johns Hopkins University School of Medicine
Internship, Transitional Year
Catholic Medical Centers
Residency, Dermatology
Icahn School of Medicine At Mount Sinai
Fellowship, Clinical Pharmacology
Mount Sinai Hospital
Certifications
American Board of Dermatology
Awards
2008
Chief Resident
Mount Sinai Hospital
Research
Use of new combinations and treatments.
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP
- EmblemHealth - HIP-Medicare
- Empire Blue Cross Blue Shield - Commercial/Exchange
- Empire Blue Cross Blue Shield - Medicare
- HealthFirst Medicare
- Horizon NJ
- Medicare - NJ
- Medicare - NY
- Multiplan PHCS
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Commercial
- United Health Care - Empire Plan
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Novel 2% Salicylic Acid Cleanser With Polymeric Cleansing Technology Treats Acne Without Compromising Skin Barrier. Rabab Hussain, Dara Miller, Thomas Shyr, Diana Friscia, Wen Hwa Li, Ramine Parsa, Joshua Zeichner. Journal of Drugs in Dermatology
- Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants With Moderate-to-Severe Acne: The Patient Journey. Hilary Baldwin, Julie C. Harper, Joshua A. Zeichner, Zoe D. Draelos, Lawrence F. Eichenfield, Michael Gold, Linda Stein Gold, Leon Kircik. Journal of Drugs in Dermatology
- Efficacy and Safety of Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel in Participants with Moderate-to-Severe Acne: The Patient Journey. Hilary Baldwin, Julie C. Harper, Joshua A. Zeichner, Zoe D. Draelos, Lawrence F. Eichenfield, Michael Gold, Linda Stein Gold, Leon H. Kircik, Eric Guenin. SKIN: Journal of Cutaneous Medicine
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
4.7 out of 5
Care Provider’s Concern
4.7 out of 5
Likelihood to Recommend Care Provider
4.6 out of 5
Dr Zeichner is highly knowledgeable, skilled and competent. He has helped me a lot in diagnosing and treating cancer of my skin in various places.
We discussed my concerns, history up to present. Dr. Z examined the areas of concern. He outlined a preliminary treatment plan and sought my input and agreement. He took a biopsy of a problem ares, and worked with me and the nurse to get new prescriptions in the record, making sure I understood the new protocol . I felt completely confident in the depth of his knowledge and concern for me as a patient. I am grateful to have Dr. Z as my dermatologist.
Provider upfront and honest my specific problem not his area of expertise- I appreciated that. [...]
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Zeichner during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- Regeneron Pharmaceuticals
- Pfizer Inc.
- Botanix
- Incyte Corporation
- UCB S.A.
- Galderma S.A.
- Sun Pharma
- AbbVie Inc.
- Arcutis
- Kenvue
- Ortho Dermatologics, Inc.
- Dermavant
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.